These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37225270)

  • 1. Testing the applicability and additional value of a consultation round after the consensus meeting in the development of two core outcome sets.
    Beune IM; Jansen L; Grooten I; Ganzevoort W; Painter RC; Gordijn S
    BMJ Open; 2023 May; 13(5):e060531. PubMed ID: 37225270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core Outcome Set for GROwth restriction: deVeloping Endpoints (COSGROVE).
    Healy P; Gordijn S; Ganzevoort W; Beune I; Baschat A; Khalil A; Kenny L; Bloomfield F; Daly M; Papageorghiou A; Devane D
    Trials; 2018 Aug; 19(1):451. PubMed ID: 30134949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A core outcome set for hyperemesis gravidarum research: an international consensus study.
    Jansen L; Koot MH; Van't Hooft J; Dean CR; Duffy J; Ganzevoort W; Gauw N; Goes BY; Rodenburg J; Roseboom TJ; Painter RC; Grooten IJ
    BJOG; 2020 Jul; 127(8):983-992. PubMed ID: 32056342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The windsor definition for hyperemesis gravidarum: A multistakeholder international consensus definition.
    Jansen LAW; Koot MH; Van't Hooft J; Dean CR; Bossuyt PMM; Ganzevoort W; Gauw N; Van der Goes BY; Rodenburg J; Roseboom TJ; Painter RC; Grooten IJ
    Eur J Obstet Gynecol Reprod Biol; 2021 Nov; 266():15-22. PubMed ID: 34555550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core outcome set for research studies evaluating treatments for twin-twin transfusion syndrome.
    Perry H; Duffy JMN; Reed K; Baschat A; Deprest J; Hecher K; Lewi L; Lopriore E; Oepkes D; Khalil A;
    Ultrasound Obstet Gynecol; 2019 Aug; 54(2):255-261. PubMed ID: 30520170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Core outcome set for studies investigating management of selective fetal growth restriction in twins.
    Townsend R; Duffy JMN; Sileo F; Perry H; Ganzevoort W; Reed K; Baschat AA; Deprest J; Gratacos E; Hecher K; Lewi L; Lopriore E; Oepkes D; Papageorghiou A; Gordijn SJ; Khalil A;
    Ultrasound Obstet Gynecol; 2020 May; 55(5):652-660. PubMed ID: 31273879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protocol for the Development of Core Outcome Sets for Endodontic Treatment modalities (COSET): an international consensus process.
    El Karim IA; Duncan HF; Cushley S; Nagendrababu V; Kirkevang LL; Kruse C; Chong BS; Shah PK; Lappin M; McLister C; Lundy FT; Clarke M
    Trials; 2021 Nov; 22(1):812. PubMed ID: 34789318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus study.
    Meher S; Cuthbert A; Kirkham JJ; Williamson P; Abalos E; Aflaifel N; Bhutta ZA; Bishop A; Blum J; Collins P; Devane D; Ducloy-Bouthors AS; Fawole B; Gülmezoglu AM; Gutteridge K; Gyte G; Homer C; Mallaiah S; Smith JM; Weeks AD; Alfirevic Z
    BJOG; 2019 Jan; 126(1):83-93. PubMed ID: 29920912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Core Outcome Set and Minimum Reporting Set for intervention studies in growth restriction in the NEwbOrN (COSNEON): study protocol for a Delphi study.
    Knol M; Wang H; Bloomfield F; Piet T; Damhuis S; Khalil A; Ganzevoort W; Gordijn S
    Trials; 2019 Aug; 20(1):511. PubMed ID: 31420053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Core Outcome Set for the prevention and treatment of fetal GROwth restriction: deVeloping Endpoints: the COSGROVE study.
    Healy P; Gordijn SJ; Ganzevoort W; Beune IM; Baschat A; Khalil A; Kenny L; Bloomfield FH; Daly M; Kirkham J; Devane D; Papageorghiou AT
    Am J Obstet Gynecol; 2019 Oct; 221(4):339.e1-339.e10. PubMed ID: 31152710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a core outcome set for diabetes after pregnancy prevention interventions (COS-DAP): a study protocol.
    Nielsen KK; O'Reilly S; Wu N; Dasgupta K; Maindal HT
    Trials; 2018 Dec; 19(1):708. PubMed ID: 30594221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e-Delphi process and consensus meeting.
    Langbroek GB; Wolkerstorfer A; Horbach SER; Spuls PI; Kelly KM; Robertson SJ; van Raath MI; Al-Niaimi F; Kono T; Boixeda P; Laubach HJ; Badawi AM; Rubin AT; Haedersdal M; Manuskiatti W; van der Horst CMAM; Ubbink DT;
    Br J Dermatol; 2022 Nov; 187(5):730-742. PubMed ID: 35762296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What outcomes should be measured in feline chronic kidney disease treatment trials? Establishing a core outcome set for research.
    Doit H; Dean RS; Duz M; Finch NC; Brennan ML
    Prev Vet Med; 2021 Jul; 192():105348. PubMed ID: 34022713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A core outcome set for studies of gestational diabetes mellitus prevention and treatment.
    Egan AM; Bogdanet D; Griffin TP; Kgosidialwa O; Cervar-Zivkovic M; Dempsey E; Allotey J; Alvarado F; Clarson C; Cooray SD; de Valk HW; Galjaard S; Loeken MR; Maresh MJA; Napoli A; O'Shea PM; Wender-Ozegowska E; van Poppel MNM; Thangaratinam S; Crowther C; Biesty LM; Devane D; Dunne FP;
    Diabetologia; 2020 Jun; 63(6):1120-1127. PubMed ID: 32193573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment.
    Tallouzi MO; Mathers JM; Moore DJ; Bucknall N; Calvert MJ; Murray PI; Denniston AK;
    Ophthalmology; 2021 Aug; 128(8):1209-1221. PubMed ID: 33515595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of core outcome sets and core outcome measures for central visual impairment, visual field loss and ocular motility disorders due to stroke: a Delphi and consensus study.
    Rowe FJ; Hepworth LR; Kirkham JJ
    BMJ Open; 2022 Mar; 12(3):e056792. PubMed ID: 35304397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A core outcome set for evaluating the effectiveness of mixed-diagnosis falls prevention interventions for people with Multiple Sclerosis, Parkinson's Disease and stroke.
    O'Malley N; Coote S; Staunton FM; O'Connor E; Clifford AM
    PLoS One; 2023; 18(11):e0294193. PubMed ID: 37956176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study protocol: developing, disseminating, and implementing a core outcome set for selective fetal growth restriction in monochorionic twin pregnancies.
    Khalil A; Duffy JMN; Perry H; Ganzevoort W; Reed K; Baschat AA; Deprest J; Gratacos E; Hecher K; Lewi L; Lopriore E; Oepkes D; Papageorghiou A; Gordijn SJ;
    Trials; 2019 Jan; 20(1):35. PubMed ID: 30626413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Core outcome set for fetal Myelomeningocele (COSMiC): study protocol.
    Altoukhi S; Whitehead CL; Ryan G; Deprest J; Joyeux L; Gallagher K; Drake J; Church P; Horn D; Diambomba Y; Carvalho JCA; Van Mieghem T
    Trials; 2020 Aug; 21(1):732. PubMed ID: 32825852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
    Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
    BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.